Cargando…

Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression

Detalles Bibliográficos
Autores principales: Song, Huajie, Li, Dan, Wang, Xiaojing, Fang, Erhu, Yang, Feng, Hu, Anpei, Wang, Jianqun, Guo, Yanhua, Liu, Yang, Li, Hongjun, Chen, Yajun, Huang, Kai, Zheng, Liduan, Tong, Qiangsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426150/
https://www.ncbi.nlm.nih.gov/pubmed/37580734
http://dx.doi.org/10.1186/s13045-023-01493-7
_version_ 1785089995569102848
author Song, Huajie
Li, Dan
Wang, Xiaojing
Fang, Erhu
Yang, Feng
Hu, Anpei
Wang, Jianqun
Guo, Yanhua
Liu, Yang
Li, Hongjun
Chen, Yajun
Huang, Kai
Zheng, Liduan
Tong, Qiangsong
author_facet Song, Huajie
Li, Dan
Wang, Xiaojing
Fang, Erhu
Yang, Feng
Hu, Anpei
Wang, Jianqun
Guo, Yanhua
Liu, Yang
Li, Hongjun
Chen, Yajun
Huang, Kai
Zheng, Liduan
Tong, Qiangsong
author_sort Song, Huajie
collection PubMed
description
format Online
Article
Text
id pubmed-10426150
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104261502023-08-16 Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression Song, Huajie Li, Dan Wang, Xiaojing Fang, Erhu Yang, Feng Hu, Anpei Wang, Jianqun Guo, Yanhua Liu, Yang Li, Hongjun Chen, Yajun Huang, Kai Zheng, Liduan Tong, Qiangsong J Hematol Oncol Retraction Note BioMed Central 2023-08-15 /pmc/articles/PMC10426150/ /pubmed/37580734 http://dx.doi.org/10.1186/s13045-023-01493-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Retraction Note
Song, Huajie
Li, Dan
Wang, Xiaojing
Fang, Erhu
Yang, Feng
Hu, Anpei
Wang, Jianqun
Guo, Yanhua
Liu, Yang
Li, Hongjun
Chen, Yajun
Huang, Kai
Zheng, Liduan
Tong, Qiangsong
Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
title Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
title_full Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
title_fullStr Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
title_full_unstemmed Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
title_short Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
title_sort retraction note: hnf4a-as1/hnrnpu/ctcf axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426150/
https://www.ncbi.nlm.nih.gov/pubmed/37580734
http://dx.doi.org/10.1186/s13045-023-01493-7
work_keys_str_mv AT songhuajie retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT lidan retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT wangxiaojing retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT fangerhu retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT yangfeng retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT huanpei retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT wangjianqun retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT guoyanhua retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT liuyang retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT lihongjun retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT chenyajun retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT huangkai retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT zhengliduan retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression
AT tongqiangsong retractionnotehnf4aas1hnrnpuctcfaxisasatherapeutictargetforaerobicglycolysisandneuroblastomaprogression